Stay updated on Daratumumab in Untreated Myeloma: Transplant Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page.

Latest updates to the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the list.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry (v3.3.2) was added and the previous revision (v3.2.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe notice about government funding lapse and NIH operating status was removed from the page; it did not affect study data or history entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check58 days agoChange DetectedThe latest version (2025-03-26) updates the Record History with changes to Recruitment Status and Study Status.SummaryDifference0.2%

- Check86 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference12%

- Check93 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.3%

Stay in the know with updates to Daratumumab in Untreated Myeloma: Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page.